Evolus Return on Tangible Equity 2016-2025 | EOLS

Current and historical return on tangible equity values for Evolus (EOLS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Evolus Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.06B $-0.08B 89.24%
2024-12-31 $-0.05B $-0.06B 89.69%
2024-09-30 $-0.06B $-0.06B 88.71%
2024-06-30 $-0.05B $-0.05B 77.66%
2024-03-31 $-0.06B $-0.05B 80.00%
2023-12-31 $-0.06B $-0.09B 79.23%
2023-09-30 $-0.06B $-0.09B 91.64%
2023-06-30 $-0.07B $-0.08B 115.28%
2023-03-31 $-0.07B $-0.06B 159.55%
2022-12-31 $-0.07B $-0.05B 246.67%
2022-09-30 $-0.08B $-0.04B 535.59%
2022-06-30 $-0.08B $-0.02B -4457.14%
2022-03-31 $-0.07B $0.00B -443.75%
2021-12-31 $-0.05B $0.01B -1105.88%
2021-09-30 $-0.14B $0.03B 394.37%
2021-06-30 $-0.13B $0.03B 251.43%
2021-03-31 $-0.14B $-0.05B 196.42%
2020-12-31 $-0.16B $-0.15B 265.04%
2020-09-30 $-0.07B $-0.04B 273.47%
2020-06-30 $-0.08B $-0.04B 278.99%
2020-03-31 $-0.10B $-0.02B 327.87%
2019-12-31 $-0.09B $0.00B 333.94%
2019-09-30 $-0.09B $-0.06B 348.51%
2019-06-30 $-0.07B $-0.04B 1536.84%
2019-03-31 $-0.05B $-0.01B 1073.68%
2018-12-31 $-0.05B $0.01B 471.79%
2018-09-30 $-0.03B $0.02B 60.30%
2018-06-30 $-0.02B $-0.04B 38.71%
2018-03-31 $-0.01B $-0.03B 15.73%
2017-12-31 $-0.01B $-0.15B 13.07%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.589B $0.266B
Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.616B 27.97
Boston Scientific (BSX) United States $153.611B 38.46
Stryker (SYK) United States $149.817B 31.33
EssilorLuxottica (ESLOY) France $128.259B 0.00
Medtronic (MDT) Ireland $112.441B 15.94
Lonza Group Ag (LZAGY) Switzerland $50.320B 0.00
Haleon (HLN) United Kingdom $45.596B 26.03
ResMed (RMD) United States $37.597B 28.24
GE HealthCare Technologies (GEHC) United States $34.163B 16.22
Agilent Technologies (A) United States $33.875B 22.08
Terumo (TRUMY) Japan $24.770B 32.17
Koninklijke Philips (PHG) Netherlands $22.956B 16.11
Insulet (PODD) United States $21.162B 83.07
Zimmer Biomet Holdings (ZBH) United States $18.315B 11.76
Baxter (BAX) United States $15.236B 11.38
Smith & Nephew SNATS (SNN) United Kingdom $13.113B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.723B 23.40
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $3.900B 17.42
Perrigo (PRGO) Ireland $3.676B 9.32
Haemonetics (HAE) United States $3.609B 16.44
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.192B 23.54
QuidelOrtho (QDEL) United States $1.976B 13.59
LeMaitre Vascular (LMAT) United States $1.875B 41.91
AtriCure (ATRC) United States $1.561B 0.00
Acuren (TIC) United States $1.375B 0.00
AdaptHealth (AHCO) United States $1.248B 12.67
Phibro Animal Health (PAHC) United States $1.212B 15.49
Green Thumb Industries (GTBIF) United States $1.163B 26.16
Neogen (NEOG) United States $1.081B 13.83
BioLife Solutions (BLFS) United States $1.036B 0.00
InMode (INMD) Israel $0.954B 9.62
Kestra Medical Technologies (KMTS) United States $0.757B 0.00
Owens & Minor (OMI) United States $0.669B 5.55
Maravai LifeSciences Holdings (MRVI) United States $0.662B 0.00
CeriBell (CBLL) United States $0.622B 0.00
Curaleaf Holdings (CURLF) Canada $0.553B 0.00
Tilray Brands (TLRY) Canada $0.507B 0.00
Valneva SE (VALN) France $0.488B 0.00
Capricor Therapeutics (CAPR) United States $0.452B 0.00
Surmodics (SRDX) United States $0.424B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.360B 0.00
VAREX IMAGING (VREX) United States $0.344B 12.67
SNDL (SNDL) Canada $0.326B 0.00
Quanterix (QTRX) United States $0.315B 0.00
Sanuwave Health (SNWV) United States $0.284B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
ZimVie (ZIMV) United States $0.263B 11.94
Sanara MedTech (SMTI) United States $0.259B 0.00
Brainsway (BWAY) Israel $0.253B 66.85
Aurora Cannabis (ACB) Canada $0.249B 73.83
Cresco Labs (CRLBF) United States $0.247B 0.00
OraSure Technologies (OSUR) United States $0.228B 0.00
Canopy Growth (CGC) Canada $0.221B 0.00
Biote (BTMD) United States $0.218B 6.14
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
High Tide (HITI) Canada $0.188B 0.00
Organigram Global (OGI) Canada $0.186B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.13
Omeros (OMER) United States $0.180B 0.00
Verano Holdings (VRNOF) United States $0.173B 0.00
Exagen (XGN) United States $0.148B 0.00
Vireo Growth (VREOF) United States $0.147B 0.00
FitLife Brands (FTLF) United States $0.129B 15.90
Apyx Medical (APYX) United States $0.098B 0.00
Fonar (FONR) United States $0.096B 12.37
Jin Medical (ZJYL) China $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
TerrAscend (TSNDF) Canada $0.088B 0.00
MacroGenics (MGNX) United States $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.076B 0.00
Quipt Home Medical (QIPT) United States $0.075B 0.00
Agape ATP (ATPC) $0.070B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Nephros (NEPH) United States $0.043B 58.29
Modular Medical (MODD) United States $0.040B 0.00
Safety Shot (SHOT) United States $0.038B 0.00
United-Guardian (UG) United States $0.038B 13.10
Rockwell Medical (RMTI) United States $0.027B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.015B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Senestech (SNES) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00